MFN2 and metabolic syndrome: Sotagliflozin is able to improve mitochondrial fission and reactive oxygen species production in a metabolic-syndrome-related rat model of heart failure with preserved ejection fraction [116] Ipragliflozin is able to restore the levels of Opa1 and Mfn2 to their normal values in an experimental model (rats under a high-fat diet) [117].